Communities engaged in dengue vector control in Uruguay
Uruguay does not have dengue, but its proximity to neighboring countries where the disease is prevalent puts it at risk. However, a community approach to reducing breeding among the dengue-carrying mosquitoes is starting to pay off.

Alumni profile:
A career investigating malaria parasite drug resistance
For some kids, it’s outer space, for others dinosaurs. But for a Sudanese boy by the name of Gehad el-Ghazali, it was the human body — how it works and why, the cells and circuits, the muscles and blood — that sparked an early interest in science.


More news

Workshop on how to expand research data sharing

‘Data is power’ was the sentiment of the opening address by Susan Veldsman, from the Academy of Science of South Africa at a recent workshop on research data sharing held in Stellenbosch, South Africa. The consensus among the more than 65 African and international experts was that Africa can benefit if equitable terms and funding can be established.

Research plans endorsed at TDR annual scientific and technical review

“Full steam ahead” was the theme at this year’s annual meeting of TDR’s 13-member Scientific and Technical Advisory Committee (STAC), where members endorsed the updates on work for 2014/15 as well as the plans for 2016/17. The meeting was overseen by a new Chair, Professor Charles Mgone, who is the Executive Director of EDCTP, the European & Developing Countries Clinical Trials Partnership.

New funding to increase capacity for Ebola outbreak research

A new call for proposals to increase research capacity is now available from EDCTP, TDR and MRC-UK. The call is intended to support projects that will develop and strengthen research capacity in sub-Saharan Africa to conduct high quality health research during infectious disease emergencies such as the Ebola virus disease (EVD) outbreak in West Africa.

New funding for continued development of onchocerciasis treatment moxidectin

The Global Health Investment Fund (GHIF) has committed US$ 10 million to support completing the dossier for the registration of moxidectin for the treatment of onchocerciasis. Medicines Development for Global Health (MDGH), an Australian not-for-profit biopharmaceutical company, will be managing the work.


TDR Co-Sponsors

News from TDR Director, John Reeder

John Reeder

This month we are seeing the fruits of several TDR initiatives that are being taken up and expanded. This includes the transfer of the onchocerciasis treatment moxidectin to an Australian company for registration, a new guide for strengthening community health care worker programmes, and a very positive independent evaluation of SORT IT, the operational research and training programme.

About TDR: making a difference

TDR, the Special Programme for Research and Training in Tropical Diseases, is a global programme of scientific collaboration that helps facilitate, support and influence efforts to combat diseases of poverty. TDR is hosted at the World Health Organization (WHO), and is sponsored by the United Nations Children’s Fund (UNICEF), the United Nations Development Programme (UNDP), the World Bank and WHO.